AXS26_DigitalGuide_Final pages - Flipbook - Page 127
Powering Access Execution
Biopharma market access teams rely on AccessSync® to
equip field teams with integrated tools to consistently
execute their access strategies with confidence.
Visit Us at
Booth #1709
All-in-one specialty pharmacy support.
Undivided focus on patient outcomes.
One partner.
One system.
One point of
accountability.
Complete focus on
your therapy from
first patient through
commercialization
and beyond.
Built exclusively for rare disease with end-to-end,
fully integrated services.
Rare disease patients deserve undivided attention, not fragmented care across
multiple providers.
Anovo delivers end-to-end services in one exclusive partnership:
• 3PL / Specialty Wholesale Distribution
• Early Access Programs with Seamless
• Patient Support Services
Commercial Transition
• Specialty Pharmacy
Your EAP Advantage
Choose Anovo for early access AND commercial distribution. No provider changes.
No relearning your therapy. When FDA approves, your commercial program is already
running because we built it together during your EAP.
Meet us at Asembia
Alan Erck
Chief Commercial Officer
Alan.Erck@AnovoRx.com
anovorx.com
Dedicated. Exclusive. Unique.
Natalie Kelly
VP, Business Development & Marketing
Natalie.Kelly@AnovoRx.com
Jordan McLean
VP, Growth & Strategy
Jordan.McLean@AnovoRx.com